Table 4.

Demographics and clinical presentation of CD patients

PatientAge (yrs)SexDuration of illness (yrs)Direction of CDClinically apparent OHM?Response to BTXDuration since BTX (months)
169F29LC-LYesGood3
248F12TC-L, RCNoModerate3
387F25LC-RYesPoor3.5
469F41LC-LNoGood3
558F2TC-L, ACNoGood3
674F12LC-R, TC-RYesModerate3
749F7TC-L, LC-LNoGood3
857F12TC-LYesGood3
940M9LC-R, TC-L, RCNoGood3
1061F10AC, LC-RNoGood3
1161F4TC-RNoModerate3
1269F23LC-RNoGood3
1359F19TC-L, LC-RYesModerate3
1448F9LC-R, TC-LNoGood3
  • BTX, Botulinum toxin; R, Right; L, Left, TC, torticollis, AC, anterocollis, LC, laterocollis, RC, retrocollis; yrs, years.